Most Ghana Clinic Patients Had More Than One Cardiometabolic Condition
Researchers in Ghana looked at a group of 203 adults. All of them visited special clinics at a large hospital in Cape Coast. The work ran from 17 May 2023 to 30 April 2024. The team wanted to count how often heart and metabolism problems travel together. Those problems include high blood pressure, type 2 diabetes, metabolic syndrome, and chronic kidney disease.
The numbers were striking. More than 80 percent of the group had at least two of these conditions. Over 80 percent were overweight or obese. More than two thirds met the rules for metabolic syndrome. Even though many people were on treatment, blood pressure and blood sugar often stayed poorly controlled. That gap invites a simple question about what medicine alone can fix.
Obesity stood out as the strongest independent link to chronic kidney disease. The adjusted odds ratios sat around 7 to 8 for Obese class I and II. Taking glucose-lowering medicine tracked with better blood sugar control. That result showed an odds ratio of 7.16, with a 95 percent confidence interval from 3.31 to 15.47, and it was statistically significant.
The team also gathered lifestyle details through structured questionnaires. They genotyped several candidate variants, including TCF7L2 rs7903146, AGT rs699, ACE rs4343, LEPR rs1137101, ADRB3 rs4994, KCNJ11 rs5219, PPARG rs1801282, and APOL1 risk variants. Multivariable logistic regression tested the links. Then receiver operating characteristic curves compared clinical and lifestyle models, genetic models, and combined models.